Background and Objective: There is paucity of data on the pattern and factors affecting the management outcome of patients with spina bifida cystica in the Ife-Ijesa zone, Nigeria. This study was designed to address this research question. Method: One hundred and six consecutive cases of spina bifida cystica who presented in our hospital from January 1990 to December 2004 were reviewed. We obtained information on sociodemographic factors, medical history and management as well as clinical outcome. SPSS was used to analyze the data. Result: Males constituted 54.7% and females 45.2% of cases. Mortality was high in those presented after the 4th week of life (p = 0.04). The malformation occurred in the lumbar and lumbosacral regions in 77.4%. Myelomeningocele was the most common type (86.8%). Hydrocephalus was recorded in 53.8% of patients. Surgical closure was done for 91.5% of the patients. About 77% of all the patients were discharged while 22.7% died. This was significantly related to age at presentation (p = 0.04) and infection before surgery (p = 0.045). Postoperative complications were more frequent in patients with ruptured lesions (p = 0.025), a larger size of defect (p = 0.028) and a lower birth weight (p = 0.006). Conclusion: Myelomeningocele is the most common type of spina bifida cystica in our environment. Late presentation and preoperative infection are associated with high mortality in our patients.

1.
Mitchell LE, Adzick NS, Malchiome J, Pasquarillo PS, Suilon LN, Whitehead AS: Spina bifida. Lancet 2004;364:1885–1895.
2.
Kabre A, Badiane SB, Sakho V, Ba MC, Et Gueye M: Genetic and etiologic aspects of spina bifida in Senegal: apropos of Zil cases collected at the neurosurgical clinic UHC of Fann. Dakar Med 1994;39:113–119.
3.
McDonnell GN, Meijean JP: Issue of medical management in adults with spina bifida. Child Nerv Syst 2000;16:2411–2417.
4.
Airede KI: Neural tube defects in the middle belt of Nigeria. J Trop Pediatr 1992;38:27–30.
5.
Rennie JM: Central nervous system malformation; in Rennie JM, Robertson MRC (eds): Textbook of Neurology, ed 3. Edinburgh, Churchill Livingstone, 1999, pp 1297–1311.
6.
Haslam RHA: Congenital anomalies of the central nervous system; in Behrman RE, Kliegman RM, Jenso HB (eds): Nelson Textbook of Paediatrics, ed 16. Philadelphia, Saunders, 2000, pp 1803–1810.
7.
National Population Commission (Nigeria) and ORC Macro: National Demographic and Health Survey 2003. Calverton, National Population Commission and ORC Macro, 2004, pp 108–109.
8.
Shehu BB, Ameh EA, Ismail NJ: Spina bifida cystica: selective management in Zaria, Nigeria. Ann Trop Paediatr 2000;20:239–242.
9.
Mabogunje OA: Spina bifida cystica in northern Nigeria. Child Nerv Syst 1990;6:103–106.
10.
Uba AF, Isamade ES, Chirdan LB, Edino ST, Igun GO: Epidemiology of neural tube defects in north central Nigeria. Afr J Paediatr Surg 2004;1:16–19.
11.
Scott RM, Moore MR: Myelomeningcele repair; in Park TS (ed): Spinal Dysraphism. Boston, Blackwell Scientific Publications, 1992, pp 48–57.
12.
Akar Z: Myelomeningocele. Surg Neurol 1995;43:113–118.
13.
Charney EB, Weller SC, Sutton LW, Bruce DA, Schut LB: Management of the newborn with myelomeningocele: time for a decision-making process. Pediatrics 1985;75:58–64.
14.
Jinadu MK, Ojofeitimi EO, Dare ZH: Effect of antenatal care and parity on birth weights of Nigerian children. J R Soc Health 1983;103:194–195.
15.
Ansman JI, Slavin KV: Spina bifida, anencephaly and folic acid: what do they have to do with neurosurgery? Surg Neural 1995;42:120–121.
16.
Cherian A, Seena S, Bullock RK, Antony AC: Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 2005;366:930–931.
17.
Antony AC: Vegetarianism and vitamin B12 (cobalamin) deficiency (editorial). Am J Clin Nutr 2003;78:3–6.
18.
Ray JG, Blom HJ: Vitamin B12 insufficiency and the risk of fetal neural tube defects. Q J Med 2003;96:289–295.
19.
Elwood JM, Little J, Elwood JH: Epidemiology and Control of Neural Tube Defects. New York, Oxford University Press, 1992.
20.
Asindi A, Al-Shehri A: Neural tube defects in the Asir region of Saudi Arabia. Ann Saudi Med 2001;21:26–29.
21.
Bowman RM, McLone DG, Grant JA, Tomita T: Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg 2001;34:114–120.
22.
Kumar R, Singh SN: Spinal dysraphism: trends in northern India. Pediatr Neurosurg 2003;33:133–145.
23.
Kumar R, Basal KK, Chbabra DK: Occurrence of split cord malformation in meningomyelocele: complex spina bifida. Pediatr Neurosurg 2002;36:119–127.
24.
Jindal A, Mahapatra AK, Kamal R: Spinal dysraphism. Indian J Pediatr 1999;66:697–705.
25.
McLone DG, Naidich TP: Myelomeningocele: outcome and late complications; in Mclaurin RL, Venes JL, Schut L, Epstein F (eds): Pediatric Neurosurgery: Surgery of the Developing Nervous System. Philadelphia, Saunders, 1989, pp 53–70.
26.
Oyewole A, Adeloye A, Adeyokunnu AA: Psychosocial and cultural factors associated with the management of spina bifida cystica in Nigeria. Dev Med Child Neural 1985;27:498–503.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.